Skip to main navigation Skip to search Skip to main content

Idarucizumab, a Specific Dabigatran Reversal Agent, Reduces Blood Loss in a Porcine Model of Trauma With Dabigatran Anticoagulation

Research output: Contribution to journal › Comment/Letter to the editor › Academic › peer-review

Original languageEnglish
Pages (from-to)1518-1519
Number of pages2
JournalJournal of the American College of Cardiology
Volume66
Issue number13
DOIs
Publication statusPublished - 29 Sept 2015

Cite this